PACS Group (NYSE:PACS) Coverage Initiated at UBS Group

Research analysts at UBS Group began coverage on shares of PACS Group (NYSE:PACSGet Free Report) in a research note issued to investors on Wednesday, MarketBeat Ratings reports. The brokerage set a “buy” rating and a $50.00 price target on the stock. UBS Group’s target price would indicate a potential upside of 29.87% from the company’s current price.

A number of other equities research analysts have also weighed in on the company. Stephens boosted their target price on PACS Group from $37.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, August 13th. Truist Financial boosted their target price on PACS Group from $36.00 to $44.00 and gave the company a “buy” rating in a research note on Thursday, August 15th. Macquarie began coverage on PACS Group in a research note on Friday, June 28th. They issued an “outperform” rating and a $35.00 target price for the company. Oppenheimer boosted their target price on PACS Group from $32.00 to $40.00 and gave the company an “outperform” rating in a research note on Tuesday, August 13th. Finally, Citigroup began coverage on PACS Group in a research note on Wednesday, September 11th. They issued a “buy” rating and a $45.00 target price for the company. Eight equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $39.13.

Get Our Latest Stock Report on PACS

PACS Group Trading Down 1.3 %

PACS opened at $38.50 on Wednesday. The business has a 50-day moving average price of $38.59. PACS Group has a 12-month low of $22.61 and a 12-month high of $42.25. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.71 and a quick ratio of 1.71.

PACS Group (NYSE:PACSGet Free Report) last posted its quarterly earnings data on Monday, August 12th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.42). The firm had revenue of $981.80 million during the quarter, compared to analysts’ expectations of $919.22 million. PACS Group’s revenue was up 29.1% compared to the same quarter last year. On average, research analysts anticipate that PACS Group will post 1.03 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Amalgamated Bank bought a new position in shares of PACS Group in the 2nd quarter worth approximately $25,000. Sandia Investment Management LP bought a new position in shares of PACS Group in the 2nd quarter worth approximately $295,000. The Manufacturers Life Insurance Company purchased a new stake in shares of PACS Group in the 2nd quarter worth approximately $302,000. SG Americas Securities LLC purchased a new stake in shares of PACS Group in the 3rd quarter worth approximately $548,000. Finally, Oppenheimer Asset Management Inc. purchased a new stake in shares of PACS Group in the 2nd quarter worth approximately $552,000.

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Featured Stories

Analyst Recommendations for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.